Active Ingredient(s): Zileuton
FDA Approved: * December 9, 1996
Pharm Company: * CRITICAL
Category: Asthma

Zileuton (trade name Zyflo) is an orally active inhibitor of 5-lipoxygenase, and thus inhibits leukotrienes (LTB4, LTC4, LTD4, and LTE4) formation, used for the maintenance treatment of asthma. Zileuton was introduced in 1996 by Abbott Laboratories and is now marketed in two formulations by Cornerstone Therapeutics Inc. under the brand names Zyflo and Zyflo CR. The original immediate-release formulation, Zyflo, is taken four times per day. The extended-release formulation, Zyflo CR, is take... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Zyflo 600 mg Oral Tablet
NDC: 10122-901
Cornerstone Therapeutics Inc.

Related Brands

Drugs with the same active ingredients